Age and gender of the patient | Clinical features | MRI findings | Day of initiation of plasmapheresis | No. of cycles/volume exchanged | Outcome | References | ||
---|---|---|---|---|---|---|---|---|
Pontine | Extra-pontine | Clinical | Radiological | |||||
29 F | Tetraparesis, areflexia, bulbar dysfunction | + | − | NA | 24,700 mL | Partial | Unchanged | [8] |
20 F | Spastic tetraparesis, bulbar dysfunction | + | − | NA | 5243 mL | Partial | Unchanged | [8] |
30 F | Tetraparesis, pseudo-bulbar palsy, nystagmus | + | − | NA | 18,270 mL | Complete | Unchanged | [8] |
59 F | Pseudo-bulbar palsy, flaccid tetraplegia, ophthalmoplegia, hyper-reflexia | + | − | A week after the onset of neurological manifestations | 37,300 mL | Partial | Unchanged | [9] |
40 F | Tetraparesis, pseudo-bulbar palsy, diplopia | + | − | Immediately after MRI confirmation of ODS | 4394 mL | Partial | NA | [10] |
71 F | Spastic tetraparesis, hyper-reflexia, dysphagia | + | + | 23rd day after rapid sodium correction | 3840 mL | Complete | The signals were reduced in size but remained | [6] |
50 F | Drowsy, spastic tetraparesis, areflexia, bulbar dysfunction | + | − | 20th day after the onset of neurological manifestations | 7 cycles | Complete | NA | (7) |